This is why Estia Health Ltd shares are getting crushed again

Estia Health Ltd (ASX:EHE) shares are out of their trading halt and getting crushed following a downgrade to its earnings guidance just weeks after its previous update.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Although they have recovered slightly now, the shares of Estia Health Ltd (ASX: EHE) were down by as much as 12.3% in early trade today after they emerged from their trading halt.

The company's share price is now down just 6.4% at $3.09.

Yesterday the embattled aged care operator placed its shares in a trading halt whilst it prepared an update on its first quarter trading. With the market fearing the worst, the shares of its rivals Regis Healthcare Ltd (ASX: REG) and Japara Healthcare Ltd (ASX: JHC) came under heavy selling pressure.

It would appear as though the market was right to be concerned about what Estia Health might announce. This morning the company advised that it is downgrading its full year underlying earnings before interest, tax, depreciation, and amortisation (EBITDA) guidance.

Just over a month ago the company advised that it expected FY 2017 underlying EBITDA to come in at least 13% higher year on year at almost $105 million. But following a review it now expects underlying EBITDA for FY 2017 will be between $86 million to $90 million.

According to the release, the principal contributors to the shocking reduction in its guidance are the result of a lower projected occupancy growth rate and a reappraisal of the company's anticipated non-labour operating expenses.

I find it incredibly worrying for the company to reduce its full-year EBITDA guidance so significantly in such a short space of time. As a result, I am not at all surprised to see investors head for the exits in their droves this morning.

It is worth noting though that since the previous guidance was provided both its founder Peter Arvanitis and its CEO Paul Gregersen have left the company. So it would be unfair to place the blame on the current management team, who were evidently left with a huge mess to clean up.

Whilst this could potentially be a sign that the worst is now over, I personally would suggest investors stay clear of Estia Health no matter how cheap it appears.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »